- call +1-201-465-4211
- email sales@mrinsights.biz
An antibody (Ab), also known as an immunoglobulin (Ig), is a large, Y-shaped protein produced mainly by plasma cells that is used by the immune system to neutralize pathogens such as pathogenic bacteria and viruses. The antibody recognizes a unique molecule of the pathogen, called an antigen, via the Fab's variable region.
Scope of the Report:
This report focuses on the Antibodies in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Based on types, the global antibodies market is seperated into polyclonal antibodies, monoclonal antibodies and antibody-drug conjugates. Among others, monoclonal antibodies posses the biggest market share in 2017 and is expected to increase over the forecast period.
Antibodies can be widely used in different sectorsluding hospitals, research institutions and long-term care facilities. Hospitals are the biggest downstream consumer of antibodies due to intens demand of monoclonal antibodies.
The worldwide market for Antibodies is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Novartis
F. Hoffmann-La Roche
Johnson & Johnson Services
Amgen
Bristol-Myers Squibb
AbbVie
Eli Lilly
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monoclonal antibodies
Polyclonal antibodies
Antibody drug conjugates
Market Segment by Applications, can be divided into
Hospitals
Long-term care facilities
Research institutes
There are 15 Chapters to deeply display the global Antibodies market.
Chapter 1, to describe Antibodies Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Antibodies, with sales, revenue, and price of Antibodies, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Antibodies, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Antibodies market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Antibodies sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Antibodies Introduction
1.2 Market Analysis by Type
1.2.1 Monoclonal antibodies
1.2.2 Polyclonal antibodies
1.2.3 Antibody drug conjugates
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Long-term care facilities
1.3.3 Research institutes
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Antibodies Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 F. Hoffmann-La Roche
2.2.1 Business Overview
2.2.2 Antibodies Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 F. Hoffmann-La Roche Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson Services
2.3.1 Business Overview
2.3.2 Antibodies Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Services Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Amgen
2.4.1 Business Overview
2.4.2 Antibodies Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Amgen Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bristol-Myers Squibb
2.5.1 Business Overview
2.5.2 Antibodies Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bristol-Myers Squibb Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 AbbVie
2.6.1 Business Overview
2.6.2 Antibodies Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AbbVie Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Eli Lilly
2.7.1 Business Overview
2.7.2 Antibodies Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Eli Lilly Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Antibodies Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Antibodies Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Antibodies Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Antibodies Manufacturer Market Share in 2017
3.3.2 Top 6 Antibodies Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Antibodies Market Analysis by Regions
4.1 Global Antibodies Sales, Revenue and Market Share by Regions
4.1.1 Global Antibodies Sales and Market Share by Regions (2013-2018)
4.1.2 Global Antibodies Revenue and Market Share by Regions (2013-2018)
4.2 North America Antibodies Sales and Growth Rate (2013-2018)
4.3 Europe Antibodies Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Antibodies Sales and Growth Rate (2013-2018)
4.5 South America Antibodies Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Antibodies Sales and Growth Rate (2013-2018)
5 North America Antibodies by Countries
5.1 North America Antibodies Sales, Revenue and Market Share by Countries
5.1.1 North America Antibodies Sales and Market Share by Countries (2013-2018)
5.1.2 North America Antibodies Revenue and Market Share by Countries (2013-2018)
5.2 United States Antibodies Sales and Growth Rate (2013-2018)
5.3 Canada Antibodies Sales and Growth Rate (2013-2018)
5.4 Mexico Antibodies Sales and Growth Rate (2013-2018)
6 Europe Antibodies by Countries
6.1 Europe Antibodies Sales, Revenue and Market Share by Countries
6.1.1 Europe Antibodies Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Antibodies Revenue and Market Share by Countries (2013-2018)
6.2 Germany Antibodies Sales and Growth Rate (2013-2018)
6.3 UK Antibodies Sales and Growth Rate (2013-2018)
6.4 France Antibodies Sales and Growth Rate (2013-2018)
6.5 Russia Antibodies Sales and Growth Rate (2013-2018)
6.6 Italy Antibodies Sales and Growth Rate (2013-2018)
7 Asia-Pacific Antibodies by Countries
7.1 Asia-Pacific Antibodies Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Antibodies Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Antibodies Revenue and Market Share by Countries (2013-2018)
7.2 China Antibodies Sales and Growth Rate (2013-2018)
7.3 Japan Antibodies Sales and Growth Rate (2013-2018)
7.4 Korea Antibodies Sales and Growth Rate (2013-2018)
7.5 India Antibodies Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Antibodies Sales and Growth Rate (2013-2018)
8 South America Antibodies by Countries
8.1 South America Antibodies Sales, Revenue and Market Share by Countries
8.1.1 South America Antibodies Sales and Market Share by Countries (2013-2018)
8.1.2 South America Antibodies Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Antibodies Sales and Growth Rate (2013-2018)
8.3 Argentina Antibodies Sales and Growth Rate (2013-2018)
8.4 Colombia Antibodies Sales and Growth Rate (2013-2018)
9 Middle East and Africa Antibodies by Countries
9.1 Middle East and Africa Antibodies Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Antibodies Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Antibodies Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Antibodies Sales and Growth Rate (2013-2018)
9.3 UAE Antibodies Sales and Growth Rate (2013-2018)
9.4 Egypt Antibodies Sales and Growth Rate (2013-2018)
9.5 Nigeria Antibodies Sales and Growth Rate (2013-2018)
9.6 South Africa Antibodies Sales and Growth Rate (2013-2018)
10 Global Antibodies Market Segment by Type
10.1 Global Antibodies Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Antibodies Sales and Market Share by Type (2013-2018)
10.1.2 Global Antibodies Revenue and Market Share by Type (2013-2018)
10.2 Monoclonal antibodies Sales Growth and Price
10.2.1 Global Monoclonal antibodies Sales Growth (2013-2018)
10.2.2 Global Monoclonal antibodies Price (2013-2018)
10.3 Polyclonal antibodies Sales Growth and Price
10.3.1 Global Polyclonal antibodies Sales Growth (2013-2018)
10.3.2 Global Polyclonal antibodies Price (2013-2018)
10.4 Antibody drug conjugates Sales Growth and Price
10.4.1 Global Antibody drug conjugates Sales Growth (2013-2018)
10.4.2 Global Antibody drug conjugates Price (2013-2018)
11 Global Antibodies Market Segment by Application
11.1 Global Antibodies Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Long-term care facilities Sales Growth (2013-2018)
11.4 Research institutes Sales Growth (2013-2018)
12 Antibodies Market Forecast (2018-2023)
12.1 Global Antibodies Sales, Revenue and Growth Rate (2018-2023)
12.2 Antibodies Market Forecast by Regions (2018-2023)
12.2.1 North America Antibodies Market Forecast (2018-2023)
12.2.2 Europe Antibodies Market Forecast (2018-2023)
12.2.3 Asia-Pacific Antibodies Market Forecast (2018-2023)
12.2.4 South America Antibodies Market Forecast (2018-2023)
12.2.5 Middle East and Africa Antibodies Market Forecast (2018-2023)
12.3 Antibodies Market Forecast by Type (2018-2023)
12.3.1 Global Antibodies Sales Forecast by Type (2018-2023)
12.3.2 Global Antibodies Market Share Forecast by Type (2018-2023)
12.4 Antibodies Market Forecast by Application (2018-2023)
12.4.1 Global Antibodies Sales Forecast by Application (2018-2023)
12.4.2 Global Antibodies Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Antibodies Picture
Table Product Specifications of Antibodies
Figure Global Sales Market Share of Antibodies by Types in 2017
Table Antibodies Types for
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
